A retrospective cohort study with 7,077 initially NAFLD-free participants reported that after 7 years of follow-up, elevated serum ApoB levels independently predict an increased risk for incident NAFLD (20). Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.